Higher leverage · 2 cases · 2 scored
Directional evidence
Industry subdomain insight
This view tracks 40 documented AI deployments. Therapeutics research is the most common use-case type with 5 cases.
Executive brief
Therapeutics research is 60× more concentrated here than across AI overall.
Cases
40
18 in the last 6 months
Innovativeness
100% of evidence scored
Cases trend
Early signal: Medical imaging — a promising impact-for-effort profile in limited evidence (2 cases).
Concentration compares this view's share of source-linked deployments for a use-case type with that type's share across the full catalog. Momentum is a peer-relative 0-100 score based on recent deployment volume, acceleration, recent evidence share, and evidence depth. Quantified outcome medians appear only when at least 4 reported metrics support them; smaller supported samples are marked early evidence.
Relative leverage
1 of 7 scored types sit in the higher-leverage area; Medical imaging is an early signal based on 2 scored cases; Life sciences innovation (3 cases) is the largest high-impact investment signal.
Use-case types
Hover to highlight · Click to openTap a type to open
Higher leverage · 2 cases · 2 scored
Directional evidence
High-impact investments · 3 cases · 3 scored
Directional evidence
Efficient extensions · 2 cases · 2 scored
Directional evidence
Review trade-offs · 5 cases · 5 scored
Efficient extensions · 2 cases · 2 scored
Directional evidence
Review trade-offs · 2 cases · 2 scored
Directional evidence
Efficient extensions · 3 cases · 3 scored
Directional evidence
Each dot is one Clinical Trials in Healthcare use-case type, sitting at the mean build effort and business impact of its scored cases, positioned relative to the other scored types shown. The dashed crosshair is the peer median, so the split compares leverage within this view.
The dashed indigo zone marks higher leverage: above-median impact for at-or-below-median effort. Dot size reflects scored cases; impact and effort figures in the list are the true 1–5 averages.
The use-case types deployed most often in this view, ranked by volume and coloured by recent momentum.
20 use-case types in view; Therapeutics research leads with 5 cases, and 9 of the 19 cases shown were published in the last 6 months. 7 more types have a single case each and are not charted.
Therapeutics research
AI applied to therapeutics research.
Drug discovery
Accelerates drug discovery by predicting promising molecules and targets.
Life sciences innovation
Applies AI across life-sciences R&D to speed discovery and development.
Clinical documentation
Generates and structures clinical notes from patient encounters, cutting clinicians' administrative burden.
Federated learning
AI applied to federated learning.
Healthcare workflow automation
Automates clinical and administrative healthcare workflows to reduce staff burden.
Medical imaging
Analyzes medical images to help clinicians detect and diagnose conditions.
The use-case types this view over-indexes on versus the whole corpus — what makes this slice different from AI overall.
Therapeutics research is 60× more common here than across all cases — the strongest signal of what sets this view apart.
1× = corpus average · points show how many times more common each type is here.
Lift compares each type's share of this view against its share of all 3,826 cases. 32 of the 40 cases here are type-classified.
How the documented deployments in this view were built — custom engineering (Build), an off-the-shelf assistant (Buy), or low-code assembly (Compose).
Full report
Expand any section for the detail behind the summary above.
Most-reported outcome themes: New product / capability (30 cases), Speed & agility (24 cases), Risk & compliance (16 cases), and Customer experience & trust (13 cases). Expand for the per-type breakdown.
Reported challenge examples: Addressed logistics of large-scale donor recruitment across over 1,500 centers (1 case), Administrative burdens, disparate systems, and lack of process standards impaired timely activation of clinical trials (1 case), Antibiotic resistance causes millions of deaths annually and traditional antibiotic development is slow and costly, taking over 10 years (1 case), Biomedical researchers faced the challenge of accelerating AI-powered research without compromising patient privacy and meeting strict regulatory compliance such as HIPAA (1 case), and Characterizing patients was time-consuming, occupying up to 52% of clinicians' workdays (1 case). Evidence is still limited; expand to inspect the source cases.
Adoption pulse: 18 of the 40 cases in this view were published in the last 6 months. Expand for the adoption curve.
Questions answered here:
Featured cases: